21 May 2009
Surgical complications of simultaneous pancreas-kidney transplantation: A 20 year-experience at one center
A Kwiatkowski, G Michalak, J Czerwiński, S Fesołowicz, M Bieniasz, M Wszoła, P Domagała, W Lisik, D Wasiak, M Durlik, J Wałaszewski, W Rowiński, A ChmuraAnn Transplant 2009; 14(1): 23-23 :: ID: 880281
Abstract
Background: Despite new immunosuppression protocols, cellular rejection has still an impact on survival after lung transplantation (LTx). The aim of the study was to analyse unspecific inflammatory markers like C-reactive protein (CRP) and fibrinogen in the context of cellular rejection.
Material/Methods: The study group included 7 LTx patients (2 women and 5 men, mean age 43.6±12.1 yr, BMI 21.0±7.1) at rejection periods (n=10) before and after methylprednisolonum administration (group A and B, respectively). The control group (group C) included 10 lung transplant recipients (3 women and 7 men, mean age 46.6±14.5 yr, BMI 18.2±3.0) at clinically stable period. Serum CRP levels were measured using a commercially available kit with the turbidimetric method and fibrinogen levels were measured by routine Clauss method.
Results: Intriguingly, no significant differences in average CRP values between analyzed groups were found (average CRP value of group C, A and B was 40.5±42.4, 42.3±52.0, 32.8±28.5; respectively). Significantly increased average fibrinogen value in group B was revealed when compared to group C (662.3±27.8 vs. 490.0±128.3, p<0.05; respectively).
Conclusions: Non-invasive diagnosis of acute cellular rejection in lung transplantation recipients is extremely difficult. Higher fibrinogen concentrations might be associated with increased risk of rejection.
Keywords: Kidney Transplantation, Pancreas Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






